サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386578

間葉系幹細胞市場レポート：2030年までの動向、予測、競合分析

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

間葉系幹細胞市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

間葉系幹細胞の動向と予測

世界の間葉系幹細胞市場は、2024年から2030年までのCAGRが13.1%で、2030年までに推定66億米ドルに達すると予想されています。この市場の主な促進要因は、糖尿病、がん、自己免疫疾患などの慢性疾患の罹患率の上昇、再生医療の魅力の高まり、間葉系幹細胞を利用した革新的な治療法の創出を目指すバイオ製薬企業の研究開発努力の急増です。間葉系幹細胞の世界市場の将来は、疾患モデリング、創薬開発、幹細胞バンキング、組織工学、毒性研究市場において有望です。

間葉系幹細胞市場の洞察

Lucintelは、同種間葉系幹細胞の臨床使用における強い安全性の実績が注目され、同種間葉系幹細胞の移植は、免疫反応を誘発する可能性が低く、免疫抑制特性があるため、画期的な細胞ベースの治療法になると予測しています。

間葉系幹細胞は、生命を脅かす様々な疾患に対する潜在的な治療オプションとして、その有効性と安全性を評価することを目的とした臨床試験が米国内で現在進行中であるため、予測期間中、北米が最大の地域であることに変わりはないと思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の間葉系幹細胞市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の間葉系幹細胞市場の動向（2018-2023）と予測（2024-2030）
  • ワークフロー別の世界の間葉系幹細胞市場
    • 細胞の調達と単離
    • 培養と凍結保存
    • 差別化
    • 特性評価
  • タイプ別の世界の間葉系幹細胞市場
    • 自己由来
    • 同種異系
  • 用途別の世界の間葉系幹細胞市場
    • 疾患モデリング
    • 創薬と発見
    • 幹細胞バンク
    • ヒト組織工学
    • 毒物学研究
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の間葉系幹細胞市場
  • 北米間葉系幹細胞市場
  • 欧州間葉系幹細胞市場
  • アジア太平洋間葉系幹細胞市場
  • その他地域間葉系幹細胞市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • ワークフロー別の世界の間葉系幹細胞市場の成長機会
    • タイプ別の世界の間葉系幹細胞市場の成長機会
    • 用途別の世界の間葉系幹細胞市場の成長機会
    • 地域別の世界の間葉系幹細胞市場の成長機会
  • 世界の間葉系幹細胞市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の間葉系幹細胞市場の能力拡大
    • 世界の間葉系幹細胞市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • BrainStorm Cell
  • Stemedica Cell Technologies
  • Merck
目次

Mesenchymal Stem Cell Trends and Forecast

The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

A more than 150-page report is developed to help in your business decisions.

Mesenchymal Stem Cell by Segment

The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.

Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Autologous
  • Allogeneic

Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Mesenchymal Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Mesenchymal Stem Cell Market Insights

Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Features of the Global Mesenchymal Stem Cell Market

Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).

Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mesenchymal stem cell market size?

Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.

Q.2 What is the growth forecast for mesenchymal stem cell market?

Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?

Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

Q4. What are the major segments for mesenchymal stem cell market?

Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.

Q5. Who are the key mesenchymal stem cell market companies?

Answer: Some of the key mesenchymal stem cell companies are as follows:

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Q6. Which mesenchymal stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mesenchymal stem cell market by workflow (cell sourcing & isolation, culture & cryopreservation, differentiation, and characterization), type (autologous and allogeneic), application (disease modelling, drug development & discovery, stem cell banking, tissue engineering, toxicology studies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Mesenchymal Stem Cell Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Mesenchymal Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Mesenchymal Stem Cell Market by Workflow
    • 3.3.1: Cell Sourcing & Isolation
    • 3.3.2: Culture & Cryopreservation
    • 3.3.3: Differentiation
    • 3.3.4: Characterization
  • 3.4: Global Mesenchymal Stem Cell Market by Type
    • 3.4.1: Autologous
    • 3.4.2: Allogeneic
  • 3.5: Global Mesenchymal Stem Cell Market by Application
    • 3.5.1: Disease Modelling
    • 3.5.2: Drug Development & Discovery
    • 3.5.3: Stem Cell Banking
    • 3.5.4: Tissue Engineering
    • 3.5.5: Toxicology Studies
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Mesenchymal Stem Cell Market by Region
  • 4.2: North American Mesenchymal Stem Cell Market
    • 4.2.1: North American Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.2.2: North American Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.3: European Mesenchymal Stem Cell Market
    • 4.3.1: European Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.3.2: European Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.4: APAC Mesenchymal Stem Cell Market
    • 4.4.1: APAC Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.4.2: APAC Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.5: ROW Mesenchymal Stem Cell Market
    • 4.5.1: ROW Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.5.2: ROW Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Workflow
    • 6.1.2: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Type
    • 6.1.3: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Application
    • 6.1.4: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Region
  • 6.2: Emerging Trends in the Global Mesenchymal Stem Cell Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Mesenchymal Stem Cell Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mesenchymal Stem Cell Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Cell Applications
  • 7.3: Axol Biosciences
  • 7.4: Cytori Therapeutics
  • 7.5: STEMCELL Technologies
  • 7.6: Cyagen Biosciences
  • 7.7: Celprogen
  • 7.8: BrainStorm Cell
  • 7.9: Stemedica Cell Technologies
  • 7.10: Merck